Erin Twohy

854 total citations
18 papers, 385 citations indexed

About

Erin Twohy is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Erin Twohy has authored 18 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Erin Twohy's work include Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (4 papers) and Dementia and Cognitive Impairment Research (3 papers). Erin Twohy is often cited by papers focused on Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (4 papers) and Dementia and Cognitive Impairment Research (3 papers). Erin Twohy collaborates with scholars based in United States and Malaysia. Erin Twohy's co-authors include Evanthia Galanis, Tanios Bekaii‐Saab, David Schiff, Jan C. Buckner, Caterina Giannini, Fang‐Shu Ou, S. Keith Anderson, Donna Niedzwiecki, Briant Fruth and Timothy J. Kaufmann and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Erin Twohy

18 papers receiving 380 citations

Peers

Erin Twohy
Lenka Krsková Czechia
Patrizia Lastella Italy
Trevor Singh United States
Jörn Rüssel Germany
Cinzia Candiotto Italy
Anna Estival Spain
Guo‐Hao Huang China
Francesca Castiglione Italy
Shiyu Tong China
Steven Schoenfeld United States
Lenka Krsková Czechia
Erin Twohy
Citations per year, relative to Erin Twohy Erin Twohy (= 1×) peers Lenka Krsková

Countries citing papers authored by Erin Twohy

Since Specialization
Citations

This map shows the geographic impact of Erin Twohy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Twohy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Twohy more than expected).

Fields of papers citing papers by Erin Twohy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Twohy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Twohy. The network helps show where Erin Twohy may publish in the future.

Co-authorship network of co-authors of Erin Twohy

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Twohy. A scholar is included among the top collaborators of Erin Twohy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Twohy. Erin Twohy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Webb, Mason, Terry C. Burns, Erin Twohy, et al.. (2023). Efficacy and safety study of neoadjuvant efineptakin alfa (NT-I7) and pembrolizumab in recurrent glioblastoma.. Journal of Clinical Oncology. 41(16_suppl). TPS2085–TPS2085. 3 indexed citations
3.
Galanis, Evanthia, S. Keith Anderson, Erin Twohy, et al.. (2022). Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance). Neuro-Oncology Advances. 4(1). vdac041–vdac041. 6 indexed citations
4.
Alden, Eva, Emily S. Lundt, Erin Twohy, et al.. (2022). Mayo normative studies: A conditional normative model for longitudinal change on the Auditory Verbal Learning Test and preliminary validation in preclinical Alzheimer's disease. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 14(1). e12325–e12325. 13 indexed citations
5.
Stricker, Nikki H., Erin Twohy, Sabrina M. Albertson, et al.. (2022). Mayo‐PACC: A parsimonious preclinical Alzheimer's disease cognitive composite comprised of public‐domain measures to facilitate clinical translation. Alzheimer s & Dementia. 19(6). 2575–2584. 8 indexed citations
6.
Stricker, Nikki H., Erin Twohy, Sabrina M. Albertson, et al.. (2022). Diagnostic accuracy of the Stricker Learning Span and Mayo Test Drive Composite for amnestic Mild Cognitive Impairment.. Alzheimer s & Dementia. 18(S7). 2 indexed citations
7.
Brastianos, Priscilla K., Erin Twohy, Susan Geyer, et al.. (2021). Alliance A071601: Phase II trial of BRAF/MEK inhibition in newly diagnosed papillary craniopharyngiomas.. Journal of Clinical Oncology. 39(15_suppl). 2000–2000. 17 indexed citations
8.
Goodman, Karyn A., Fang‐Shu Ou, Nathan C. Hall, et al.. (2021). Randomized Phase II Study of PET Response–Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial. Journal of Clinical Oncology. 39(25). 2803–2815. 71 indexed citations
9.
Brastianos, Priscilla K., Erin Twohy, Elizabeth R. Gerstner, et al.. (2020). Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations.. Journal of Clinical Oncology. 38(15_suppl). 2502–2502. 22 indexed citations
10.
Kozono, David, Elad Sharon, Jennifer Le‐Rademacher, et al.. (2020). Alliance A151804: Establishment of a national biorepository to advance studies of immune-related adverse events.. Journal of Clinical Oncology. 38(15_suppl). TPS3154–TPS3154. 4 indexed citations
11.
Brastianos, Priscilla K., Erin Twohy, Carey K. Anders, et al.. (2020). Alliance A071701: Genomically guided treatment trial in brain metastases.. Journal of Clinical Oncology. 38(15_suppl). TPS2573–TPS2573. 6 indexed citations
12.
Jaeckle, Kurt A., Erin Twohy, Jesse G. Dixon, et al.. (2019). Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG). Journal of Neuro-Oncology. 143(3). 573–581. 8 indexed citations
13.
14.
Sikov, William M., Mei‐Yin C. Polley, Erin Twohy, et al.. (2019). CALGB (Alliance) 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) and bevacizumab (Bev) in triple-negative breast cancer (TNBC).. Journal of Clinical Oncology. 37(15_suppl). 591–591. 33 indexed citations
15.
16.
Schiff, David, Kurt A. Jaeckle, S. Keith Anderson, et al.. (2018). Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572. Cancer. 124(7). 1455–1463. 50 indexed citations
17.
Goodman, Karyn A., Nathan C. Hall, Tanios Bekaii‐Saab, et al.. (2018). Survival outcomes from CALGB 80803 (Alliance): A randomized phase II trial of PET scan-directed combined modality therapy for esophageal cancer.. Journal of Clinical Oncology. 36(15_suppl). 4012–4012. 23 indexed citations
18.
Galanis, Evanthia, S. Keith Anderson, Nicholas Butowski, et al.. (2017). NCCTG N1174: Phase I/comparative randomized phase (Ph) II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma (GBM) (Alliance).. Journal of Clinical Oncology. 35(15_suppl). 2023–2023. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lenka Krsková Breakdown of academic impact, for papers by Patrizia Lastella Breakdown of academic impact, for papers by Trevor Singh Breakdown of academic impact, for papers by Jörn Rüssel Breakdown of academic impact, for papers by Cinzia Candiotto Breakdown of academic impact, for papers by Anna Estival Breakdown of academic impact, for papers by Guo‐Hao Huang Breakdown of academic impact, for papers by Francesca Castiglione Breakdown of academic impact, for papers by Shiyu Tong Breakdown of academic impact, for papers by Steven Schoenfeld
Rankless by CCL
2026